CDK4/6抑制剂在HR阳性/HER2阴性乳腺癌新辅助治疗中的研究进展
肖红艳, 张丽娜, 顾 林
Research progress in CDK4/6 inhibitors in neoadjuvant therapy of HR-positive HER2-negative breast cancer
XIAO Hongyan, ZHANG Lina, GU Lin
肿瘤
.
2022, (12): 835
-844
.
DOI: 10.3781/j.issn.1000-7431.2022.2111-0864
